About Careers Internship MedBlog Contact us

Takeda’s Experimental Drug More Effective in Lowering Blood Sugar Levels Than Generics

by Kathy Jones on February 27, 2012 at 9:24 PM
 Takeda’s Experimental Drug More Effective in Lowering Blood Sugar Levels Than Generics

A study sponsored by Takeda Pharmaceutical has found that its experimental diabetes drug was more effective than older generic medicine in lowering blood sugar with fewer side effects.

Around 426 patients with type 2 diabetes took part in the study which tested the effectiveness of Takeda's TAK 875 drug in lowering blood sugar. The study was conducted by researchers from University of Michigan who gave five different doses (6.25 mg, 25 mg, 50 mg, 100 mg, and 200 mg) of TAK 875 to 303 patients while the remaining participants received glimepiride.


The researchers found that patients who received TAK 875 dosage of 25 mg and above managed to reduce their blood sugar levels by 48 percent within 12 weeks compared to just 40 percent among those who took glimepiride.

Writing in their report, published in The Lancet, the researchers said, "We are truly excited about the potential of TAK-875 and are eager to conduct larger trials to find out how well this drug works, how safe it is and what its place is in the treatment of diabetes."

Source: Medindia
Font : A-A+



Recommended Readings

Latest Diabetes News

Mastering Blood Sugar and Weight Loss
Recent study underscores tirzepatide's supremacy over semaglutide in regulating blood sugar and achieving weight loss.
Time Your Physical Activity Well to Stay Out of Diabetes
Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.
Staying Late at Night? Late Morning Wake-up? Your Chance of Diabetes may be High
Late sleepers and late risers may both have a higher risk of developing diabetes.
New Hope for Type 1 Diabetes: Semaglutide Reduces Insulin Dependency
Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.
Bacteria Treatment Shows Potential Against Insulin Resistance & Diabetes
The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Takeda’s Experimental Drug More Effective in Lowering Blood Sugar Levels Than Generics Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests